# M-tron Industries, Inc.: overview MPTI · NYSE · CIK 1902314 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mpti.md) · [Financials](/companies/mpti/financials.md) · [Filings](/companies/mpti/filings.md) · [Insiders](/companies/mpti/insiders.md) Latest reported revenue: [$15.1m](/filings/0001437749-26-027371.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-027371). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [13.2](/filings/0001437749-26-009844.md) | [12.8](/filings/0001437749-26-009844.md) | [12.7](/filings/0001437749-26-016784.md) | [13.3](/filings/0001437749-26-027371.md) | [14.2](/filings/0001437749-26-009844.md) | [14.2](/filings/0001437749-26-009844.md) | [14.7](/filings/0001437749-26-016784.md) | [15.1](/filings/0001437749-26-027371.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [22.1%](/filings/0001437749-26-009844.md) | [20.1%](/filings/0001437749-26-009844.md) | [15.8%](/filings/0001437749-26-016784.md) | [13.9%](/filings/0001437749-26-027371.md) | [18.0%](/filings/0001437749-26-009844.md) | [27.3%](/filings/0001437749-26-009844.md) | [17.8%](/filings/0001437749-26-016784.md) | [11.4%](/filings/0001437749-26-027371.md) | | Net margin | % | [17.2%](/filings/0001437749-26-009844.md) | [16.7%](/filings/0001437749-26-009844.md) | [12.8%](/filings/0001437749-26-016784.md) | [11.7%](/filings/0001437749-26-027371.md) | [12.9%](/filings/0001437749-26-009844.md) | [24.1%](/filings/0001437749-26-009844.md) | [16.3%](/filings/0001437749-26-016784.md) | [12.4%](/filings/0001437749-26-027371.md) | | Diluted EPS | $ per share | [0.81](/filings/0001437749-26-009844.md) | [0.73](/filings/0001437749-26-009844.md) | [0.56](/filings/0001437749-26-016784.md) | [0.53](/filings/0001437749-26-027371.md) | [0.63](/filings/0001437749-26-009844.md) | [0.99](/filings/0001437749-26-009844.md) | [0.67](/filings/0001437749-26-016784.md) | [0.43](/filings/0001437749-26-027371.md) | | Free cash flow | $m | [1.8 d](/filings/0001437749-25-034501.md) | [1.4 d](/filings/0001437749-26-009844.md) | [1.0](/filings/0001437749-26-016784.md) | [2.0 d](/filings/0001437749-26-027371.md) | [2.7 d](/filings/0001437749-25-034501.md) | [2.3 d](/filings/0001437749-26-009844.md) | [1.7](/filings/0001437749-26-016784.md) | [2.8 d](/filings/0001437749-26-027371.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [26.7](/filings/0001564590-23-004848.md) | [31.8](/filings/0001437749-24-009243.md) | [41.2](/filings/0001437749-25-009645.md) | [49.0](/filings/0001437749-26-009844.md) | [54.4](/filings/0001437749-26-009844.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [7.9%](/filings/0001564590-23-004848.md) | [9.0%](/filings/0001437749-24-009243.md) | [10.4%](/filings/0001437749-25-009645.md) | [19.2%](/filings/0001437749-26-009844.md) | [18.9%](/filings/0001437749-26-009844.md) | | Net margin | % | [5.9%](/filings/0001564590-23-004848.md) | [5.6%](/filings/0001437749-24-009243.md) | [8.5%](/filings/0001437749-25-009645.md) | [15.6%](/filings/0001437749-26-009844.md) | [15.5%](/filings/0001437749-26-009844.md) | | Diluted EPS | $ per share | [0.59](/filings/0001564590-23-004848.md) | [0.67](/filings/0001437749-24-009243.md) | [1.28](/filings/0001437749-25-009645.md) | [2.65](/filings/0001437749-26-009844.md) | [2.62](/filings/0001437749-26-009844.md) | | Free cash flow | $m | [1.9](/filings/0001564590-23-004848.md) | [1.1](/filings/0001437749-24-009243.md) | [3.1](/filings/0001437749-25-009645.md) | [5.6](/filings/0001437749-26-009844.md) | [8.1](/filings/0001437749-26-009844.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mpti/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $25.1m | 252,972 | | Added +111,224 | | [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $20.0m | 201,280 | | Added +32,880 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.2m | 173,148 | | Added +56,380 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $15.5m | 156,595 | | Added +148,271 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $13.1m | 132,465 | | Added +70,002 | | [NEXT CENTURY GROWTH INVESTORS LLC](/funds/1134007.md) | 2026-06-30 | $12.3m | 124,173 | | Added +15,953 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.0m | 100,646 | | Added +36,715 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $9.5m | 96,005 | | Reduced −784 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.2m | 82,493 | | Added +38,210 | | [Palisades Investment Partners, LLC](/funds/1427373.md) | 2026-06-30 | $8.2m | 82,296 | | Added +1,269 | ## Recent filings [All 279 filings](/companies/mpti/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-31 | 09:05 ET | [8-K](/filings/0001437749-26-029252.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-029252 | | 2026-08-12 | 17:04 ET | [10-Q](/filings/0001437749-26-027371.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027371 | | 2026-08-12 | 17:03 ET | [8-K](/filings/0001437749-26-027369.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027369 | | 2026-06-18 | 17:05 ET | [8-K](/filings/0001437749-26-021183.md) | 5.07 Shareholder vote results | 0001437749-26-021183 | | 2026-05-14 | 08:56 ET | [8-K](/filings/0001437749-26-016895.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-016895 | | 2026-05-13 | 17:19 ET | [10-Q](/filings/0001437749-26-016784.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016784 | | 2026-05-08 | 17:12 ET | [8-K](/filings/0001437749-26-015954.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015954 | | 2026-04-30 | 08:59 ET | [DEF 14A](/filings/0001437749-26-014017.md) | Proxy statement, period 2026-06-16 | 0001437749-26-014017 | | 2026-04-27 | 09:03 ET | [8-K](/filings/0001437749-26-013378.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-013378 | | 2026-04-21 | 09:00 ET | [8-K](/filings/0001437749-26-012887.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-012887 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-009844.md), filed Mar 26, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/57e760df-7dcb-4e21-90ec-8a60b06d34b9) ## About the filer - CIK: 1902314 - Tickers: MPTI - Exchange: NYSE - SIC code: 3679 Electronic Components, NEC - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.